...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Not good for the potential of apabetalone as a Covid-19 therapy

FTW: ABBV-744 is BD2 specific - actually more so than Apabetalone. Thus, the BD2 specificity of Apabetalone is clearly within the scope of the article.

As I just posted, I think we need consider the patient population - i.e. when in the course of the infection - where it makes sense to use Apabetalone. My conclusion in lengthy post is that it makes no sense to use Apabetalone in an out-patient setting, but a lot of sense when patients get admitted to the hospital.

BR.

BKC

Share
New Message
Please login to post a reply